Metric Finance
LearnFAQ
LearnFAQ

Learn / CADL

NASDAQ: CADL

Candel Therapeutics (CADL) stock, explained like you're 5

Candel Therapeutics trades on the Nasdaq under the ticker CADL. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 761 million dollars.

Ticker
CADL
Exchange
Nasdaq
Sector
Healthcare
Industry
Biological Products (No Diagnostic Substances)
Size
Small cap, about 761 million dollars

Is Candel Therapeutics a small, medium or large cap company?

No. Candel Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 761 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Candel Therapeutics makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves CADL stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • CADL Stock On Track For Best Day In Nearly 16 Months What’s Driving The Rally? (Stocktwits)
  • (CADL) Movement Within Algorithmic Entry Frameworks (Stock Traders Daily)
  • Candel Therapeutics, Inc. (CADL) Options Chain (Yahoo! Finance Canada)
  • Analysts Expect Breakeven For Candel Therapeutics, Inc. (NASDAQ:CADL) Before Long (Simply Wall Street)
  • Why CADL Stock Plunged Nearly 15% In After Hours Trading Today (Stocktwits)

Follow CADL in your daily brief

Each trading day at 5 PM ET we post what happened to Candel Therapeutics and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow CADL

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Candel Therapeutics stock

What does Candel Therapeutics do?

Candel Therapeutics trades on the Nasdaq under the ticker CADL. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 761 million dollars.

What is the ticker symbol for Candel Therapeutics?

Candel Therapeutics trades under the ticker CADL on the Nasdaq.

What is Candel Therapeutics's market cap?

Candel Therapeutics is a small cap stock with a market cap of about 761 million dollars.

How does Candel Therapeutics make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves CADL stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow CADL stock every day?

Add CADL to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow CADL daily

A free brief on Candel Therapeutics and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • ARGX · Argenx SE
  • RVMD · Revolution Medicines
  • BNTX · BioNTech SE
  • EXEL · Exelixis

Similar stocks

  • ARGXArgenx SE
  • RVMDRevolution Medicines
  • BNTXBioNTech SE
  • EXELExelixis

Compare CADL: CADL vs ARGX, CADL vs RVMD, CADL vs BNTX

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed